Evidence map›Paper›PMID 27827912›Full record

ReviewNutrients2016

Chemopreventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives?

Santa Cirmi, Nadia Ferlazzo, Giovanni E Lombardo, Alessandro Maugeri, Gioacchino Calapai, Sebastiano Gangemi, Michele Navarra

Abstract readReview
In one paragraph

Review in Nutrients, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. International journal of molecular sciences · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. BioMed research international · 2024
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Chiral Flavonoids as Antitumor Agents.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  20. The Second Life ofMolecules (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Santa CirmiDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina I-98168, Italy. scirmi@unime.it.
Nadia FerlazzoDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina I-98168, Italy. nadiaferlazzo@email.it.
Giovanni E LombardoDepartment of Health Sciences, University "Magna Graecia" of Catanzaro, Catanzaro I-88100, Italy. gelombardo@unicz.it.
Alessandro MaugeriDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina I-98168, Italy. maugeri.alessandro@gmail.com.
Gioacchino CalapaiDepartment of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina I-98125, Italy. gcalapai@unime.it.
Sebastiano GangemiDepartment of Clinical and Experimental Medicine, University of Messina, Messina I-98125, Italy. gangemis@unime.it.
Michele NavarraDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina I-98168, Italy. mnavarra@unime.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fruits and vegetables have long been recognized as potentially important in the prevention of cancer risk. Thus, scientific interest in nutrition and cancer has grown over time, as shown by increasing number of experimental studies about the relationship between diet and cancer development. This review attempts to provide an insight into the anti-cancer effects of

Indexed as

Anticarcinogenic AgentsCitrusDietary SupplementsFlavonoidsFruitHumansNeoplasmsVegetablesAnticarcinogenic AgentsFlavonoidscancerCitruscomplementary and alternative medicinesflavonoidsfunctional foodsnatural productnutraceuticals

Identifiers

PMID27827912
PMCPMC5133085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.